VOR33 Trademark

Trademark Overview

On Friday, August 9, 2019, a trademark application was filed for VOR33 with the United States Patent and Trademark Office. The USPTO has given the VOR33 trademark a serial number of 88572660. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 3, 2023. This trademark is owned by VOR BIOPHARMA, INC.. The VOR33 trademark is filed in the Pharmaceutical Products category with the following description:

cell therapy preparations, namely, stem cells and progenitor cells for medical purposes; pharmaceutical preparations for the treatment of hematological and oncologic disorders; cells for medical or clinical use; cells for medical or clinical use, namely, cells featuring chimeric antigen receptors
vor33

General Information

Serial Number88572660
Word MarkVOR33
Filing DateFriday, August 9, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Goods and Servicescell therapy preparations, namely, stem cells and progenitor cells for medical purposes; pharmaceutical preparations for the treatment of hematological and oncologic disorders; cells for medical or clinical use; cells for medical or clinical use, namely, cells featuring chimeric antigen receptors
Pseudo MarkVORTEX THREE THREE; THIRTY THREE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVOR BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameVOR BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 30, 2022SOU EXTENSION 4 GRANTED
Thursday, June 30, 2022SOU EXTENSION 4 FILED
Thursday, June 30, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 3 GRANTED
Friday, February 4, 2022SOU EXTENSION 3 FILED
Friday, February 4, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 5, 2021SOU EXTENSION 2 GRANTED
Thursday, August 5, 2021SOU EXTENSION 2 FILED
Thursday, August 5, 2021SOU TEAS EXTENSION RECEIVED
Saturday, February 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 18, 2021SOU EXTENSION 1 GRANTED
Thursday, February 18, 2021SOU EXTENSION 1 FILED
Thursday, February 18, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 14, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, November 14, 2019PRIORITY ACTION E-MAILED
Thursday, November 14, 2019PRIORITY ACTION WRITTEN
Friday, November 8, 2019ASSIGNED TO EXAMINER
Monday, August 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 13, 2019NEW APPLICATION ENTERED

Related Keywords

cells medical clinical namely preparations featuring disorders oncologic antigen receptors